Overview Fundamentals API Earnings EOD API Sample Code Pricing

BioMark Diagnostics Inc (20B F) stock market data APIs

€0.14 0(0%) as of October 17, 2024
Price chart is built with Anychart

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.

BioMark Diagnostics Inc Financial Data Overview

0.14
0.14
-
0.14
0.14
0.121-0.216
14 787 K
90 886 K
162 K
-0.539
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '20B',
Type: 'Common Stock',
Name: 'BioMark Diagnostics Inc',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'CA09073K1084',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

BioMark Diagnostics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 162 K
  • EBITDA -1 862 611
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BioMark Diagnostics Inc Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get BioMark Diagnostics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com